NuVasive (NASDAQ:NUVA) reported Q4 EPS of $0.43, $0.08 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $305.4 million versus the consensus estimate of $310.97 million.
NuVasive (NASDAQ:NUVA) reported Q4 EPS of $0.43, $0.08 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $305.4 million versus the consensus estimate of $310.97 million.